- Home
- ARMP vs LGO Comparison
ARMP vs LGO Comparison
Compare ARMP & LGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- LGO
- Stock Information
- Founded
- ARMP N/A
- LGO 1988
- Country
- ARMP United States
- LGO Canada
- Employees
- ARMP N/A
- LGO N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- LGO
- Sector
- ARMP Health Care
- LGO
- Exchange
- ARMP Nasdaq
- LGO Nasdaq
- Market Cap
- ARMP 92.4M
- LGO 100.0M
- IPO Year
- ARMP N/A
- LGO 2007
- Fundamental
- Price
- ARMP $2.86
- LGO $1.74
- Analyst Decision
- ARMP Strong Buy
- LGO Strong Buy
- Analyst Count
- ARMP 1
- LGO 1
- Target Price
- ARMP $9.00
- LGO $3.70
- AVG Volume (30 Days)
- ARMP 12.1K
- LGO 139.6K
- Earning Date
- ARMP 11-12-2025
- LGO 11-11-2025
- Dividend Yield
- ARMP N/A
- LGO N/A
- EPS Growth
- ARMP N/A
- LGO N/A
- EPS
- ARMP N/A
- LGO N/A
- Revenue
- ARMP $6,868,000.00
- LGO $108,526,000.00
- Revenue This Year
- ARMP $8.43
- LGO N/A
- Revenue Next Year
- ARMP N/A
- LGO $54.96
- P/E Ratio
- ARMP N/A
- LGO N/A
- Revenue Growth
- ARMP 84.67
- LGO N/A
- 52 Week Low
- ARMP $0.90
- LGO $1.12
- 52 Week High
- ARMP $3.14
- LGO $2.84
- Technical
- Relative Strength Index (RSI)
- ARMP 57.54
- LGO 73.41
- Support Level
- ARMP $2.79
- LGO $1.32
- Resistance Level
- ARMP $3.03
- LGO $1.56
- Average True Range (ATR)
- ARMP 0.16
- LGO 0.07
- MACD
- ARMP 0.01
- LGO 0.02
- Stochastic Oscillator
- ARMP 62.16
- LGO 97.06
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.